Diuretic Drugs Market

Diuretic Drugs Market Outlook (2018-2028)

Diuretic Drugs are also known as 'water pills'. Diuretic drugs get rid of extra water in the body and lower blood pressure. Diuretic drugs are a class of drugs that increase the flow of urine in the body. They do so by reducing the sodium and chloride concentration in the body by removing it through the urine.

This leads the body to draw excess water from the body. The sodium and chloride concentration in the body has a marked effect on the amount of water retained within the body. Hence, most of the diuretic drugs have their effects by reducing the body’s sodium and chloride content.

Diuretic drugs are also used in combination along with various types of medications. They are useful in edema caused by renal dysfunction, and solely used as therapeutic agents to treat hypertension. As per the World Health Organization (WHO), increasing blood pressure accounts for an estimated 7.5 million deaths worldwide, and around 12.8% of the total deaths annually. Globally, the overall prevalence of blood pressure in adults aged over 25 was around 40% in 2008.

Diuretic Drugs Market: Drivers and Restraints

The growing prevalence and recurrence of kidney stones, heart failure, and high blood pressure is expected to be the major factor driving the growth of the diuretic drugs market over the forecast period. According to the World Health Organization, cardiac disease is the number one cause of death, globally. An estimated 17.2 million people die from cardiac diseases, representing a total of 31% of global deaths annually.

Approximately 7.4 million deaths were due to coronary heart disease, and approximately 6.7 million were due to stokes, which is expected to further drive the diuretic drugs market. Changes is lifestyle and eating habits are attributed to the growing prevalence of diuretic drugs. The launch and addition of new therapies is another factor contributing to the growth of the global diuretic drugs market.

Diuretic Drugs Market: Overview

The global market for diuretic drugs is expected to witness moderate growth over the forecast period. A majority of the drugs are introduced in the generic market, and thus, there exists high competition among local and regional players.

Amongst the four Diuretic drugs product types, the loop diuretic drugs segment is expected to lead the global diuretic drugs market over the forecast period. The pharmacies sub-segment under the distribution channel segment is expected to contribute a high share in the global diuretic drugs market, as it is the most accessible channel and a majority of patients are recommended Diuretic drugs.

Diuretic Drugs Market: Regional Outlook

Geographically, the global diuretic drugs market is segmented into North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global diuretic drugs market, owing to the high prevalence of the diuresis, edema and other diuretic anomalies.

The diuretic drugs market in Asia Pacific excluding Japan is expected to grow at a significant CAGR, due to the expansion of product offerings by key players. Europe is expected to have the second-largest share in the global diuretic drugs market throughout the forecast period.

Diuretic Drugs Market: Key Players

The global market for diuretic drugs is highly fragmented. Examples of some of the key players operating in the global diuretic drugs market are

• Sanofi-aventis U.S. LLC
• Centaur Pharmaceuticals Pvt Ltd
• Validus Pharmaceuticals LLC
• Meda Manufacturing GmbH
• Valeant Pharmaceuticals International Inc.
• Actavis Generics
• Pfizer Inc.
• Merck & Co. Inc.
• Paddock Laboratories LLC.
• Perrigo Pharmaceuticals Company

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved
• Technology
• Value Chain

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
• Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Diuretic Drugs Market: Segmentation

Tentatively, the global diuretic drugs market can be segmented on the basis of product type, indication, distribution channel, and geography.

By Product Type

• Loop Diuretics
• Thiazide Diuretics
• Potassium-sparing Diuretics
• Carbonic anhydrase Inhibitors

By Indication

• Hypertension
• Glaucoma
• Heart Failure
• Kidney Stones

By Distribution Channel

• Hospital Pharmacies
• Independent Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

By Geography

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific excluding Japan
• Japan
• Middle-East & Africa